Intel’s Low ROE Contributes to Stock Market Struggles
Exploring Intel's ROE reveals why its stock has fallen 23%, despite reinvestment efforts and future growth projections.
- Latest
- Trending
Exploring Intel's ROE reveals why its stock has fallen 23%, despite reinvestment efforts and future growth projections.
Allstate offloads business unit for $2B to boost growth, stock climbs.
Hannover RE's net income soars to €603 million, driven by robust P&C reinsurance performance, exceeding expectations by 13%.
Analyzing volatility, profitability, and market opportunities of SkyWater Technology and United Microelectronics stocks.
Legend Biotech reports better-than-expected quarterly earnings, $0.49 EPS above estimates, with significant revenue growth.
Foreign investors recently sold Japanese stocks, impacting market. Despite this, they're optimistic about the long-term market outlook.
Brookfield's impressive Q2 results highlight growth in renewable energy and data centers, positioning for future success.
Blue Owl Capital reports strong Q2 2024 earnings and plans merger with OBDE to enhance scale and liquidity.
Banco do Brasil, a major Latin American lender, posted a 8.2% increase in Q2 adjusted net profit, surpassing analysts' estimates.
"Credo Technology Group (CRDO) upgraded to 'buy' by TD Cowen, with price target raised to $35.00. Several analysts express confidence ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.